文献速递细菌感染、耐药与抗菌药物

性健康诊所确诊淋病奈瑟菌感染者的既往阿奇霉素暴露与阿奇霉素耐药:2012-2019年

Prior Exposure to Azithromycin and Azithromycin Resistance Among Persons Diagnosed With Neisseria gonorrhoeae Infection at a Sexual Health Clinic: 2012-2019.
PubMed 文献 · Clin Infect Dis · 2023-01-01

研究纳入2012-2019年西雅图与金县性健康诊所培养阳性淋病奈瑟菌感染者,采用多因素logistic回归分析既往12个月内阿奇霉素处方与阿奇霉素耐药淋病奈瑟菌感染的关系。共2155例患者2828次感染,6%由耐药菌株引起;既往29天内接受阿奇霉素与耐药感染强相关(调整OR 6.76,95%CI 1.76-25.90)。

要点

  • 既往29天内接受阿奇霉素与后续阿奇霉素耐药淋病奈瑟菌感染强相关(调整OR 6.76)。
  • 既往30-365天接受阿奇霉素与耐药感染无显著关联。
  • 12个月内阿奇霉素处方数与MIC水平无关,但30天内处方数与MIC水平相关。

核心结论

  • 近期个体层面阿奇霉素治疗与后续阿奇霉素耐药淋病奈瑟菌感染相关,阿奇霉素长半衰期及亚治疗浓度持续可能选择出耐药淋病奈瑟菌株。

研究设计与样本

  • 研究人群为2012-2019年西雅图与金县性健康诊所培养阳性淋病奈瑟菌感染且至少一个解剖部位分离株接受阿奇霉素敏感性检测的患者。
  • 采用多因素logistic回归分析既往12个月内阿奇霉素处方与后续阿奇霉素耐药淋病奈瑟菌感染的关系,并采用线性回归评估12个月内阿奇霉素处方数与阿奇霉素MIC水平的关联,控制人口学、行为和临床特征。

主要发现

  • 共2155例独特患者发生2828次淋病奈瑟菌感染,其中156次(6%)由阿奇霉素耐药淋病奈瑟菌引起。
  • 阿奇霉素耐药淋病奈瑟菌感染与既往29天内从性健康诊所接受阿奇霉素强相关(调整OR 6.76,95%CI 1.76-25.90),与既往30-365天接受阿奇霉素无显著关联。
  • Log阿奇霉素MIC水平与12个月内阿奇霉素处方数无关(调整相关系数0.0004,95%CI -0.04至0.037),但与30天内处方数相关(调整系数0.56,95%CI 0.13-0.98)。

关键数值与推荐

  • 阿奇霉素耐药淋病奈瑟菌定义为最小抑菌浓度(MIC)≥2.0 µg/mL。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There is conflicting evidence on whether prior azithromycin (AZM) exposure is associated with reduced susceptibility to AZM (AZMRS) among persons infected with Neisseria gonorrhoeae (NG). METHODS: The study population included Public Health-Seattle and King County Sexual Health Clinic (SHC) patients with culture-positive NG infection at ≥1 anatomic site whose isolates were tested for AZM susceptibility in 2012-2019. We used multivariate logistic regression to examine the association of time since last AZM prescription from the SHC in ≤12 months with subsequent diagnosis with AZMRS NG (minimum inhibitory concentration [MIC], ≥2.0 µg/mL) and used linear regression to assess the association between the number of AZM prescriptions in ≤12 months and AZM MIC level, controlling for demographic, behavioral, and clinical characteristics. RESULTS: A total of 2155 unique patients had 2828 incident NG infections, 156 (6%) of which were caused by AZMRS NG. AZMRS NG was strongly associated with receipt of AZM from the SHC in the prior 29 days (adjusted odds ratio, 6.76; 95% confidence interval [CI], 1.76 to 25.90) but not with receipt of AZM in the prior 30-365 days. Log AZM MIC level was not associated with the number of AZM prescriptions within ≤12 months (adjusted correlation, 0.0004; 95% CI, -.04 to .037) but was associated with number of prescriptions within <30 days (adjusted coefficient, 0.56; 95% CI, .13 to .98). CONCLUSIONS: Recent individual-level AZM treatment is associated with subsequent AZMRS gonococcal infections. The long half-life and persistence of subtherapeutic levels of AZM may result in selection of resistant NG strains in persons with recent AZM use.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Rowlinson E, Soge OO, Hughes JP, et al. Prior Exposure to Azithromycin and Azithromycin Resistance Among Persons Diagnosed With Neisseria gonorrhoeae Infection at a Sexual Health Clinic: 2012-2019. Clin Infect Dis. 2023. PMID: 36001447. doi:10.1093/cid/ciac682

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。